An investigation was announced over potential securities laws violations by MEI Pharma, Inc. in connection with certain financial statements.

Investors who purchased shares of MEI Pharma, Inc. (NASDAQ: MEIP), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether certain statements by MEI Pharma, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

San Diego, CA based MEI Pharma, Inc., a clinical-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. MEI Pharma, Inc. Reported that its Total Revenue rose from $40.69 million for the 12 months period that ended on June 30, 2022, to $48.81 million for the 12 months period that ended on June 30, 2023, and that its net Loss over those respective time periods declined from $54.45 million to $31.83 million.

Shares of MEI Pharma, Inc. (NASDAQ: MEIP) declined from $7.97 per share on May 23, 2023, to as low as $4.47 per share on January 29, 2023.

Those who purchased shares of MEI Pharma, Inc. (NASDAQ: MEIP) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.